secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABBOTT LABORATORIES (ABT)
CIK:        0000001800
Form:       8-K
Filed at:   2024-01-29T23:59:59+00:00
Accession:  0001104659-24-007725
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 1.02, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Abbott enters new $5B unsecured revolving credit facility, terminates prior facility
--------------------------------------------------------------------------------

- New 5-year revolving credit agreement with JPMorgan Chase as agent, effective Jan 29, 2024.
- Facility allows up to $5B unsecured borrowings; no outstanding borrowings at closing.
- Existing $5B facility dated Nov 2020 was terminated concurrently with no outstanding borrowings.
- Interest based on base rate or SOFR plus margin tied to Abbott's credit ratings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800/000110465924007725/0001104659-24-007725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800/000110465924007725/tm244188d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-007725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer